Sumary of Nexstim Receives System Orders from Existing Hospital Customers in Finland:
- The benefit for our customers is significant as well: our unique SmartFocus® TMS technology, that is used in both our NBS and NBT® systems, allows for both diagnostics and treatment of challenging brain diseases and disorders, offering patients a chance for a better quality of life.
- comAbout Nexstim PlcNexstim is a Finnish, globally operating medical technology company.
- Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders.
- Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®.
- It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.
- Story continuesSmartFocus® technology is used in Nexstim’s proprietary Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States.